Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT).

Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT).

Precursors to 1/3 of colorectal cancer (CRC), serrated polyps have been under-detected by screening due to their inconspicuous, non-hemorrhagic, and proximal nature. A new multi-target stool DNA test (multi-target sDNA) shows high sensitivity for both CRC and advanced adenomas. Screen detection of s...

Full description

Bibliographic Details
Main Authors:	Russell I Heigh, Tracy C Yab, William R Taylor, Fareeda T N Hussain, Thomas C Smyrk, Douglas W Mahoney, Michael J Domanico, Barry M Berger, Graham P Lidgard, David A Ahlquist
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3896420?pdf=render

Similar Items

Sessile serrated polyp detection rates after fecal immunochemical test or multitarget stool DNA test: Systematic review and meta-analysis
by: Rajat Garg, et al.
Published: (2024-04-01)

FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS
by: Luana Vilarinho BORGES, et al.

Colorectal cancer screening using immunochemical fecal occult blood test
by: Tan, Mun Chieng, et al.
Published: (2017)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.
by: S Lucas Goede, et al.
Published: (2017-01-01)

The advantages of the immunochemical test in detecting hidden blood in the stool
by: S. V. Vasiliev, et al.
Published: (2015-12-01)

Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection
by: Hongli Xu, et al.
Published: (2022-08-01)

Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms
by: Tao Zeng, et al.
Published: (2023-08-01)

Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria Analysis
by: Shaobo Mo, et al.
Published: (2021-02-01)

Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
by: Mikkelsen EM, et al.
Published: (2018-11-01)

Profiling small RNAs in fecal immunochemical tests: is it possible?
by: Einar Birkeland, et al.
Published: (2023-10-01)

Evaluation of Fecal Immunochemical Tests for Colorectal Cancer Screening
by: Jeanette M. Daly, et al.
Published: (2013-10-01)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
by: P. H. A. Wisse, et al.
Published: (2022-12-01)

The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort
by: Gonzalo Hijos-Mallada, et al.
Published: (2021-06-01)

Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis
by: Natsuki Ishida, et al.
Published: (2020-04-01)

Exploring the gut DNA virome in fecal immunochemical test stool samples reveals associations with lifestyle in a large population-based study
by: Paula Istvan, et al.
Published: (2024-02-01)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
by: Dong Ju Kim, et al.
Published: (2018-10-01)

Patients and Providers Are Amenable to Fecal Immunochemical Testing by Digital Rectal Exam
by: Harini Naidu MD, et al.
Published: (2018-09-01)

Comment on “Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population”
by: Ahlquist DA
Published: (2017-08-01)

Management of large polyps in a colorectal cancer screening program with fecal immunochemical test: a community- and population-based observational study
by: Bernard Denis, et al.
Published: (2021-11-01)

Clinical Utility of Fecal Immunochemical Transferrin Test in Gastrointestinal Bleeding Detection
by: Jong-Mi Lee, et al.
Published: (2018-09-01)

Effect of Ambient Temperature Variations on Positivity of Manual Fecal Immunochemical Tests
by: Jeanette M. Daly, et al.
Published: (2015-10-01)

A Simple and Highly Specific MassARRAY-Based Stool DNA Assay to Prioritize Follow-up Decisions in Fecal Immunochemical Test-Positive Individuals
by: Pi-Yueh Chang, et al.
Published: (2019-03-01)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
by: Efrat L. Amitay, et al.
Published: (2019-03-01)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
by: Jun Kato, et al.
Published: (2016-01-01)

Correlation between proximal serrated polyp detection and clinically significant serrated polyps: inter-endoscopist variability
by: V.F. Parra-Pérez, et al.
Published: (2021-10-01)

Risk factors of advanced colorectal neoplasia in fecal immunochemical test negative patients
by: Tomoyuki Kawada
Published: (2022-06-01)

Accuracy of a fecal immunochemical test according to outside temperature and travel time
by: Niedermaier T, et al.
Published: (2018-09-01)

Collection of non-meconium stool on fecal occult blood cards is an effective method for fecal microbiota studies in infants
by: Wendy S.W. Wong, et al.
Published: (2017-09-01)

Screening Relevance of Sessile Serrated Polyps
by: Charles J. Kahi
Published: (2019-05-01)

The clinical impact of serrated colorectal polyps
by: O'Connell BM, et al.
Published: (2017-02-01)

Factors Associated With Colorectal Cancer Screening Via Immunochemical Fecal Occult Blood Test in an Average-Risk Population From a Multiethnic, Middle-Income Setting
by: Nur-Nadiatul-Asyikin Bujang, et al.
Published: (2021-12-01)

Fecal Immunochemical Testing and the Risk of Advanced Colorectal Neoplasia: A Difference-In-Difference Analysis
by: Guanglu Zhang, et al.
Published: (2024-01-01)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
by: Yinan Ren, et al.
Published: (2022-08-01)

Comment on “Positive fecal immunochemical test results are associated with non-colorectal cancer mortality”
by: Yong Eun Park
Published: (2023-03-01)

Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial
by: Carrie M. Nielson, et al.
Published: (2018-09-01)

Combining the Fecal Immunochemical Test with a Logistic Regression Model for Screening Colorectal Neoplasia
by: Feiyuan Liu, et al.
Published: (2021-03-01)

Source matters: a survey of cost variation for fecal immunochemical tests in primary care
by: Jennifer Coury, et al.
Published: (2022-02-01)

Large serrated polyps: molecular and familial links to a serrated neoplasia predisposition
by: Kalady Matthew F, et al.
Published: (2010-05-01)

Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria.
by: Gregory C Knapp, et al.
Published: (2021-01-01)

Hyperplastic Polyp? Look Again... The Impact of the New Classification for Serrated Polyps
by: Catarina Fidalgo, et al.
Published: (2014-06-01)